611 related articles for article (PubMed ID: 17696871)
1. Free resources to assist structure-based virtual ligand screening experiments.
Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
[TBL] [Abstract][Full Text] [Related]
2. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
3. Computational resources for protein modelling and drug discovery applications.
Dhaliwal B; Chen YW
Infect Disord Drug Targets; 2009 Nov; 9(5):557-62. PubMed ID: 19594423
[TBL] [Abstract][Full Text] [Related]
4. Ligand docking and structure-based virtual screening in drug discovery.
Cavasotto CN; Orry AJ
Curr Top Med Chem; 2007; 7(10):1006-14. PubMed ID: 17508934
[TBL] [Abstract][Full Text] [Related]
5. Structure-based virtual ligand screening: recent success stories.
Villoutreix BO; Eudes R; Miteva MA
Comb Chem High Throughput Screen; 2009 Dec; 12(10):1000-16. PubMed ID: 20025565
[TBL] [Abstract][Full Text] [Related]
6. AMMOS: Automated Molecular Mechanics Optimization tool for in silico Screening.
Pencheva T; Lagorce D; Pajeva I; Villoutreix BO; Miteva MA
BMC Bioinformatics; 2008 Oct; 9():438. PubMed ID: 18925937
[TBL] [Abstract][Full Text] [Related]
7. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
8. In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics.
Villoutreix BO; Bastard K; Sperandio O; Fahraeus R; Poyet JL; Calvo F; Déprez B; Miteva MA
Curr Pharm Biotechnol; 2008 Apr; 9(2):103-22. PubMed ID: 18393867
[TBL] [Abstract][Full Text] [Related]
9. Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design.
Sotriffer C; Klebe G
Farmaco; 2002 Mar; 57(3):243-51. PubMed ID: 11989803
[TBL] [Abstract][Full Text] [Related]
10. Computer-Aided Drug Design Methods.
Yu W; MacKerell AD
Methods Mol Biol; 2017; 1520():85-106. PubMed ID: 27873247
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in computer-aided drug design.
Song CM; Lim SJ; Tong JC
Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
[TBL] [Abstract][Full Text] [Related]
12. Structure-based drug design to augment hit discovery.
Kalyaanamoorthy S; Chen YP
Drug Discov Today; 2011 Sep; 16(17-18):831-9. PubMed ID: 21810482
[TBL] [Abstract][Full Text] [Related]
13. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
14. Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.
Kirchmair J; Distinto S; Schuster D; Spitzer G; Langer T; Wolber G
Curr Med Chem; 2008; 15(20):2040-53. PubMed ID: 18691055
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening for lead discovery.
Tang YT; Marshall GR
Methods Mol Biol; 2011; 716():1-22. PubMed ID: 21318897
[TBL] [Abstract][Full Text] [Related]
16. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
[TBL] [Abstract][Full Text] [Related]
17. In silico drug discovery approaches on grid computing infrastructures.
Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
[TBL] [Abstract][Full Text] [Related]
18. Ligand-binding site prediction using ligand-interacting and binding site-enriched protein triangles.
Xie ZR; Hwang MJ
Bioinformatics; 2012 Jun; 28(12):1579-85. PubMed ID: 22495747
[TBL] [Abstract][Full Text] [Related]
19. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
20. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.
Kapetanovic IM
Chem Biol Interact; 2008 Jan; 171(2):165-76. PubMed ID: 17229415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
